-transparent.png){kind=logo}
Dysfunction of neutrophils in patients infected with human immunodeficiency virus is at least partly responsible for secondary microbial diseases in these individuals, including invasive gastrointestinal (GI) candidiasis. Immunoregulatory disturbances associated with the development of AIDS in human immunodeficiency virus-infected patients exacerbates Candida albicans infection of the upper GI tract and frequently leads to oropharyngeal and esophageal candidiasis. In this article, we present the first report of a murine model of invasive GI candidiasis associated with an AIDS-related murine immunodeficiency syndrome that results from infection of C57BL/6 mice with a previously described retrovirus complex (LP-BM5). Mice of the inbred strain were infected with C. albicans by oral-intragastric inoculation as infants and with the retrovirus by the intraperitoneal route 30 days later. Control mice of the same strain were infected with C. albicans as above and subsequently infected with the avirulent, ecotropic helper virus (MBI-5). Animals were killed 90 days after retroviral challenge. Total and differential blood cell counts, CD4+ T-cell counts in the spleen, and the histopathology of the gastric mucosa of experimental and control animals were determined. The virulent LP-BM5-infected animals developed murine AIDS and showed eruptive and suppurative lesions, with associated C. albicans mainly in regions of the cardial-atrium fold of the stomach. Well-defined abscesses with entrapped C. albicans hyphae were observed in the region of the cardial-atrium fold of control mice. A significant increase in the number of C. albicans CFU in homogenized and plated segments of the GI tract was recognized in mice with murine AIDS versus the control animals. The murine model of GI candidiasis reported here permits examination of the nature of C. albicans interaction with the gastric mucosa both in the immunocompetent host under conditions in which the yeast exists predominantly as a commensal organism and in the immunosuppressed host during progressive stages of AIDS induced by a retroviral infection.
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
January 1992,
Current topics in microbiology and immunology,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
April 1991,
Science (New York, N.Y.),
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
January 1994,
Advances in experimental medicine and biology,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
October 1993,
Science (New York, N.Y.),
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
January 1991,
Immunogenetics,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
June 1997,
Investigative ophthalmology & visual science,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
June 1993,
Infection and immunity,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
August 2015,
Journal of pharmacy & bioallied sciences,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
May 1986,
Immunological investigations,
G T Cole, and
K Saha, and
K R Seshan, and
K T Lynn, and
M Franco, and
P K Wong
June 1991,
Infection and immunity,
